Pharma Growth Strategy (Case Study)
E-health, digital therapeutics and personalised therapeutics are just some of the trends shaping the present and future of today’s pharmaceutical industry. More than ever, we see empowered consumers who are self-informed about treatments and more engaged with treatment protocols. As we know, the COVID-19 pandemic has accelerated some of these trends. Pharmaceutical companies are confronted with the challenge of adapting to this new environment and using it as a transformative force for their own benefit.
A large pharmaceutical company was aiming to create a new go-to-market approach for an innovative drug across Europe.
The dynamics within which the pharmaceutical industry operates have shifted. Due to this, communications with stakeholders and the traditional sales approach needed an adjustment and, consequently, a new growth-strategy. Focusing on customer growth, we helped our client address the following questions:
"PwC helped us develop our understanding of the labeled indication market in Europe as well as how to optimally access this market and with which organizational setup, manpower and skillset. Their analysis provided us with a clear plan on how to achieve our growth targets."
Whatever industry you operate in, now’s the time to take bold steps forward to get closer to your customers.
Our series of webinars is a chance for you to explore the latest trends in customer centric transformation and see how they might help you get closer to your target audience.